TNF and inflammatory bowel disease: Anti-TNF pharmacogenetic studies, including the different anti-TNF drugs infliximab (IFX), adalimumab (ADA) and etanercept (ETN), have so far been performed in RA, inflammatory bowel disease (IBD), PA and ankylosing spondylitis (AS) patients.